Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name OBP-301
Trade Name
Synonyms OBP301|OBP 301|Telomelysin|Telomelycin|Suratadenoturev
Drug Descriptions

OBP-301 (telomelysin) is an oncolytic adenovirus that may increase tumor cell lysis and radiosensitivity (J Clin Onc 2019 37:4_suppl, 130).

CAS Registry Number 1160991-31-0
NCIT ID C119617


  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")


  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Carboplatin + OBP-301 + Paclitaxel Carboplatin OBP-301 Paclitaxel 0 1
OBP-301 OBP-301 0 0
OBP-301 + Pembrolizumab OBP-301 Pembrolizumab 0 3
OBP-301 + Radiotherapy OBP-301 Radiotherapy 0 0

Additional content available in CKB BOOST